February 9, 2023
Open to all ISPOR Members and Non-members
Title: Digital Endpoint Adoption: the How, What and Why
11:00AM EST | 4:00PM UTC | 5:00PM CET
Click here for time zone conversion
Register Now
Description
Digital health advances create opportunities throughout the drug development and commercialization lifecycle for richer evidence generation, and improved patient experiences through insights provided by continuous data collection. Focusing on clinical neurosciences (CNS), and
using first-hand experience from a Parkinson’s study, experts from Parexel discuss how to integrate eCOA science and sensor technology into clinical trials. They also describe the regulatory frameworks and access considerations as we adopt digital
endpoints to enrich the value proposition for medicines and health technologies.
Learning Objectives
• Digital endpoints – definition and context for use
• Practical tips and first-hand advice
for digital endpoint selection and implementation
• The value digital endpoint adoption can create throughout the drug development lifecycle
Moderator:
Jackie Vanderpuye-Orgle, PhD, VP, Global Head of Advanced Analytics, Parexel, Glendale, CA, USA
Speakers:
Katarzyna Kolasa, PhD, Vice President HEOR Science, Health Economics Modelling, Parexel, Basel, Switzerland
Alison Ritchie, BA, Director, Global Head of Sensor Solutions, Parexel, London, England, UK
Trisha Eustaquio, PhD, VP, Technical, Parexel, Baltimore, MD, USA
Please note: On the day of the scheduled webinar, the
first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the
full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.